# The Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects

> **NCT06214858** · PHASE1 · UNKNOWN · sponsor: **JKT Biopharma Co., Ltd.** · enrollment: 76 (estimated)

## Conditions studied

- Phase 1

## Interventions

- **DRUG:** SHEN211 tablets
- **DRUG:** SHEN211 placebo tablets

## Key facts

- **NCT ID:** NCT06214858
- **Lead sponsor:** JKT Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-14
- **Primary completion:** 2024-04-02
- **Final completion:** 2024-04-30
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2024-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06214858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06214858, "The Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06214858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*